← back to search

Nils Weinhold

New York Oncology Hematology · US
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Brain Metastases and Treatment, Cancer Genomics and Diagnostics, Glioma Diagnosis and Treatment, and Lung Cancer Treatments and Mutations.
h-index
29
citations
30,368
works
95
NIH funding
primary concept
email

Recent publications

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab
Nature Medicine 2024cited by 31position: middledoi
RAD52 resolves transcription-replication conflicts to mitigate R-loop induced genome instability
Nature Communications 2024cited by 16position: middledoi
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
Nature Biotechnology 2021cited by 266position: middledoi
Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response
Science 2019cited by 570position: middledoi
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Cell 2017cited by 2,538position: middledoi
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
Cell Reports 2017cited by 223position: middledoi
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
JCI Insight 2017cited by 128position: middledoi
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Genome biology 2016cited by 1,035position: middledoi
Comprehensive molecular characterization of gastric adenocarcinoma
Nature 2014cited by 6,465position: middledoi
Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
Journal of Clinical Oncology 2013cited by 304position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nadeem Riaz · New York Oncology Hematology4 papers (2017–2024)Timothy A. Chan · Cleveland Clinic3 papers (2017–2024)Luc G.T. Morris · Weill Cornell Medicine2 papers (2017–2019)Vladimir Makarov · Cleveland Clinic Lerner College of Medicine2 papers (2017–2019)Fengshen Kuo · Rutgers, The State University of New Jersey2 papers (2017–2019) · 2 papers (2017–2024)Raghvendra M. Srivastava · Cleveland Clinic2 papers (2019–2024)Rajarsi Mandal · Northwell Health2 papers (2017–2019)Jonathan J. Havel · Acorda Therapeutics (United States)2 papers (2017–2019)Chirag Krishna · Pfizer (United States)2 papers (2019–2024)Xiaoxiao Ma · Shandong University2 papers (2019–2024)Diego Chowell · Mount Sinai Health System2 papers (2017–2024)Rachna Shah · Loyola University Chicago2 papers (2017–2024)Matthew I. Milowsky · UNC Lineberger Comprehensive Cancer Center1 papers (2013–2013)F. Stephen Hodi · Harvard University1 papers (2017–2017)Christina S. Leslie · Center for Cancer Research1 papers (2017–2017)Thomas F. Gajewski · University of Illinois Chicago1 papers (2017–2017)Bernard H. Bochner · Faculty of 1000 (United States)1 papers (2013–2013)William H. Sharfman · Bloomberg (United States)1 papers (2017–2017)A. Ari Hakimi · Manhattan Scientifics (United States)1 papers (2017–2017)